Granahan Investment Management’s Ionis Pharmaceuticals IONS Stock Holding History

Granahan Investment Management’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-3,536	Closed	-$214K	–	189
2019 Q4	$214K	Sell	3,536 -40	-1%	-$2.38K	0.01%	178
2019 Q3	$214K	Buy	3,576 +35	+1%	+$2.28K	0.01%	177
2019 Q2	$228K	Buy	+3,541	New	+$250K	0.01%	182
2019 Q1	–	Sell	-4,316	Closed	-$233K	–	195
2018 Q4	$233K	Hold	4,316	–	–	0.02%	189
2018 Q3	$223K	Buy	+4,316	New	+$203K	0.01%	199
2017 Q1	–	Sell	-273,900	Closed	-$13.1M	–	218
2016 Q4	$13.1M	Hold	273,900	–	–	0.45%	88
2016 Q3	$10M	Hold	273,900	–	–	0.33%	120
2016 Q2	$6.38M	Buy	273,900 +37,900	+16%	+$1.22M	0.23%	136
2016 Q1	$9.56M	Buy	236,000 +24,000	+11%	+$975K	0.35%	100
2015 Q4	$13.1M	Buy	+212,000	New	+$11.4M	0.45%	84
2013 Q4	–	Sell	-842,689	Closed	-$31.6M	–	215
2013 Q3	$31.6M	Sell	842,689 -68,500	-8%	-$2.05M	0.84%	37
2013 Q2	$24.5M	Buy	+911,189	New	+$19.4M	0.7%	52

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Granahan Investment Management's IONS Position: Q1 2020 in Review

Granahan Investment Management sold out of Ionis Pharmaceuticals (IONS) in Q1 2020, closing a stake of 3,536 shares — an estimated $214K sold.

Granahan Investment Management first reported a position in IONS in Q2 2013 and held it in 12 quarters. The position peaked at $31.6M in Q3 2013. 362 funds tracked by Wall St. Rank hold IONS as of Q1 2020.

Granahan Investment Management reported no remaining Ionis Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
Granahan Investment Management sold 3,536 Ionis Pharmaceuticals shares in Q1 2020, an estimated $214K.
Granahan Investment Management first reported a position in Ionis Pharmaceuticals in Q2 2013 and held it in 12 quarters.
Granahan Investment Management's Ionis Pharmaceuticals position peaked at $31.6M in Q3 2013.
362 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2020.

Based on Granahan Investment Management's 13F filing for Q1 2020, filed 12 May 2020.